@article {Hilton2020.03.18.20038281, author = {Bridget Hilton and Daniel Wilson and Anne-Marie O{\textquoteright}Connell and Dean Ironmonger and Justine K Rudkin and Naomi Allen and Isabel Oliver and David Wyllie}, title = {Microbial isolation in English participants in the UK Biobank cohort: comparison with the general population}, elocation-id = {2020.03.18.20038281}, year = {2020}, doi = {10.1101/2020.03.18.20038281}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Our understanding of the genetic and environmental risk factors for serious bacterial infectious disease in ageing populations remains incomplete. Utilising the UK Biobank (UKB), a prospective cohort study of 500,000 men and women aged 40-69 years at recruitment (2006-2010), could help address this.Objectives To assess the feasibility of linking an England-wide dataset of microbiological isolations to UK Biobank participants, and to characterise microbial isolation from UK Biobank participants.Methods Positive microbiological isolations from patients in England, as recorded in the Public Health England Second Generation Surveillance System (SGSS), were linked to UK Biobank participants using pseudonymised identifiers.Results By January 2015, the ascertainment of laboratory reports from UK Biobank participants by SGSS was estimated at 98\%. 4.5\% of English UK Biobank participants had a positive microbiological isolate in 2015; Escherichia coli, other Enterobacteriaceae and Staphylococcus aureus were the most common isolates. Half the UKB isolates were obtained from 12 microbiology laboratories, and 70\% from 21 laboratories. Incidence rate ratios for microbial isolation, which is indicative of serious infection, from the UK Biobank cohort relative to the comparably aged general population ranged from 0.6 to 1 for different organisms, compatible with the previously described healthy participant bias in UKB.Conclusions Data on microbial isolations can be linked to UKB participants from January 2015 onwards. This linked data would offer new opportunities for research into infectious disease in older individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupported by Public Health England{\textquoteright}s Pipeline Fund. D.J.W. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (Grant 101237/Z/13/Z). D.J.W. is supported by a Big Data Institute Robertson Fellowship.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesn/a}, URL = {https://www.medrxiv.org/content/early/2020/03/20/2020.03.18.20038281}, eprint = {https://www.medrxiv.org/content/early/2020/03/20/2020.03.18.20038281.full.pdf}, journal = {medRxiv} }